{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:04:27Z","timestamp":1761494667185,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.clim.2010.02.020","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T04:42:05Z","timestamp":1269492125000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy"],"prefix":"10.1016","volume":"136","author":[{"given":"Yuchun","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoshun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaisheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan-Xin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2010.02.020_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.clindermatol.2004.07.003","article-title":"Genital warts","volume":"22","author":"Dupin","year":"2004","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.clim.2010.02.020_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/505982","article-title":"Genital human papillomavirus infection","volume":"43","author":"Dunne","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2010.02.020_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9343(97)00181-2","article-title":"Therapeutic approaches to genital warts","volume":"102","author":"Beutner","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM198509263131304","article-title":"Latent papillomavirus and recurring genital warts","volume":"313","author":"Ferenczy","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-8-76","article-title":"Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study","volume":"8","author":"Hillemanns","year":"2008","journal-title":"BMC. Infect. Dis."},{"key":"10.1016\/j.clim.2010.02.020_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/OLQ.0b013e31816c5cda","article-title":"National burden of genital warts: a first step in defining the problem","volume":"35","author":"Dempsey","year":"2008","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.clim.2010.02.020_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1146\/annurev.immunol.21.120601.141135","article-title":"Does the immune system see tumors as foreign or self?","volume":"21","author":"Pardoll","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib8","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.2741\/woodworth","article-title":"HPV innate immunity","volume":"7","author":"Woodworth","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.clim.2010.02.020_bib9","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/JVI.75.9.4283-4296.2001","article-title":"Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes","volume":"75","author":"Nees","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2010.02.020_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/viro.1999.9771","article-title":"The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha","volume":"259","author":"Barnard","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.clim.2010.02.020_bib11","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","article-title":"Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity","volume":"12","author":"Ronco","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.clim.2010.02.020_bib12","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.74.9.4174-4182.2000","article-title":"Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31","volume":"74","author":"Chang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.clim.2010.02.020_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib14","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.4049\/jimmunol.180.11.7681","article-title":"Local accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminate","volume":"180","author":"Cao","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib15","doi-asserted-by":"crossref","first-page":"727s","DOI":"10.1158\/1078-0432.CCR-06-1924","article-title":"Reversal of tumor-mediated immunosuppression","volume":"13","author":"Vieweg","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2010.02.020_bib16","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1158\/1078-0432.CCR-07-4797","article-title":"Ctla-4 blockade confers lymphocyte resistance to regulatory T-cells in advanced melanoma: surrogate marker of efficacy of tremelimumab?","volume":"14","author":"M\u00e9nard","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2010.02.020_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevImmunol.v28.i2.20","article-title":"Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide","volume":"28","author":"Brode","year":"2008","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2249.2007.03521.x","article-title":"Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes","volume":"150","author":"Audia","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00262-007-0400-6","article-title":"Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma","volume":"57","author":"Thistlethwaite","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2010.02.020_bib20","first-page":"1649","article-title":"Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells","volume":"49","author":"Awwad","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2010.02.020_bib21","first-page":"3317","article-title":"Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset","volume":"47","author":"Berd","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2010.02.020_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/eji.200324181","article-title":"CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative","volume":"34","author":"Ghiringhelli","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib23","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","article-title":"Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low dose cyclophosphamide","volume":"105","author":"Lutsiak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2010.02.020_bib24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1172\/JCI200113827","article-title":"The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT","volume":"108","author":"Wang","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2010.02.020_bib25","first-page":"5","article-title":"An evidence-based review of medical and surgical treatments of genital warts","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.clim.2010.02.020_bib26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.lgt.0000225890.21539.79","article-title":"Carbon dioxide laser vaporization of condyloma acuminata","volume":"10","author":"Padilla-Ailhaud","year":"2006","journal-title":"J. Low Genit, Tract. Dis."},{"key":"10.1016\/j.clim.2010.02.020_bib27","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clim.2010.02.020_bib28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.175.3.779","article-title":"Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF","volume":"175","author":"Robertson","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor","volume":"180","author":"Carson","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.coi.2008.09.003","article-title":"Cytokines that regulate autoimmunity","volume":"20","author":"Diveu","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ard.2008.098004","article-title":"Th17 cells in immunity and autoimmunity","volume":"67","author":"Oukka","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2010.02.020_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20082030","article-title":"Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection","volume":"206","author":"Hou","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2005.08.047","article-title":"Role of regulatory T cells in human diseases","volume":"116","author":"Chatila","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1568-9972(02)00054-X","article-title":"About CD4\u2212CD25\u2212 regulatory cells","volume":"1","author":"Asseman","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2010.02.020_bib36","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jcv.2004.10.020","article-title":"Therapy for genital human papillomavirus-related disease","volume":"32","author":"Lacey","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.clim.2010.02.020_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm0804-801","article-title":"Regulatory T cells and mechanisms of immune system control","volume":"10","author":"O'Garra","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.coi.2003.09.011","article-title":"Control of immune homeostasis by naturally arising regulatory CD4+ T cells","volume":"15","author":"Gavin","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nri2061","article-title":"FOXP3 modifies the phenotypic and functional properties of regulatory T cells","volume":"7","author":"Campbell","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib40","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.4049\/jimmunol.181.10.6923","article-title":"CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells","volume":"181","author":"Yamazaki","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib41","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1084\/jem.20040249","article-title":"In vivo instruction of suppressor commitment in naive T cells","volume":"199","author":"Apostolou","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2010.02.020_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00001432-200304000-00004","article-title":"Imiquimod","volume":"16","author":"Garland","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.clim.2010.02.020_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/jir.1995.15.537","article-title":"Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609","volume":"15","author":"Gibson","year":"1995","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.clim.2010.02.020_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/clim.1999.4804","article-title":"The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells","volume":"94","author":"Burns","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib45","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clim.2010.02.020_bib46","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.181.7.4433","article-title":"Comment on \u201cLocal accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata\u201d","volume":"181","author":"Goldstein","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib47","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.151174198","article-title":"Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection","volume":"98","author":"Iwashiro","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.clim.2010.02.020_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2010.02.020_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.0105-2896.2006.00412.x","article-title":"Regulatory T cells in virus infections","volume":"212","author":"Rouse","year":"2006","journal-title":"Immunol. Rev."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661610000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661610000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:56:26Z","timestamp":1761494186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661610000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1521661610000793"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2010.02.020","relation":{},"ISSN":["1521-6616"],"issn-type":[{"type":"print","value":"1521-6616"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2010.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}